Phase I clinical trial of Moderna mRNA vaccine for Epstein-Barr virus starting at UMass Chan
UMass Chan Medical School researchers are embarking on a clinical trial of an mRNA vaccine by Moderna against the Epstein-Barr virus (EBV), a common cause of infectious mononucleosis. EBV has also been associated with several autoimmune disorders and has been implicated in the development of several cancers, including Burkitt and Hodgkin’s lymphomas. Katherine Luzuriaga, MD […]